tickdelta
Sign in
Screener / SEC EDGAR /CIK 0000818479 /10-K filed Feb 26, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
BMRNNBIXXRAYVEEVACHCWST
Nasdaq Health care · Dental Equipment & Supplies

DENTSPLY SIRONA Inc. XRAY

XRAY quote by TradingView
Headquarters
Charlotte, NC
CEO
Daniel T. Scavilla
Next results
around Feb 25, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2021

Revenue of $4.2B through the costs to a net profit of $411.0M · income statement of the 10-K

14% operating margin
Revenue to Gross profit: $2.3BRevenue to Cost of revenue: $1.9BGross profit to Operating profit: $608.0MGross profit to Operating expenses: $1.7BOperating profit to Net profit: $411.0MOperating profit to Tax & other: $197.0MOperating expenses to R&D: $171.0MOperating expenses to SG&A: $1.6B Revenue: $4.2B REVENUE $4.2B +27% Y/Y Gross profit: $2.3B · 55% margin GROSS PROFIT $2.3B 55% margin · +42% Y/Y Cost of revenue: $1.9B · 45% of revenue COST OF REVENUE $1.9B 45% of revenue Operating profit: $608.0M · 14% margin OPERATING PROFIT $608.0M 14% margin Operating expenses: $1.7B · 41% of revenue OPERATING EXPENSES $1.7B 41% of revenue Net profit: $411.0M · 10% margin NET PROFIT $411.0M 10% margin Tax & other: $197.0M · 5% of revenue TAX & OTHER $197.0M 5% of revenue R&D: $171.0M · 4% of revenue R&D $171.0M 4% of revenue SG&A: $1.6B · 37% of revenue SG&A $1.6B 37% of revenue
Gross profit $2.3B 55% margin · +42% Y/Y
Operating profit $608.0M 14% margin
Net profit $411.0M 10% margin
The full income statement, year by year

XRAY among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.

Compare
Revenue growth: -3.0%, above 6% of 154 peers (their median 10.5%) REVENUE GROWTH -3.0% · above 6% Gross margin: 50.5%, above 27% of 107 peers (their median 63.8%) GROSS MARGIN 50.5% · above 27% Operating margin: -1.5%, above 25% of 138 peers (their median 10.2%) OPERATING MARGIN -1.5% · above 25% Net margin: -3.4%, above 25% of 153 peers (their median 6.8%) NET MARGIN -3.4% · above 25% FCF margin: 2.9%, above 27% of 144 peers (their median 10.1%) FCF MARGIN 2.9% · above 27%
XRAY Peer median Below the median

What changed

21 new risk paragraphs and 3 accounting facts worth reading about. 10-K filed Feb 26, 2026 against Feb 27, 2025.

Risk factors
21 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Receivables growing faster than revenue
Receivables +23.7% ($556.0M to $688.0M) vs revenue -3.0% ($3.8B to $3.7B), +26.7 pts apart
10-K · XBRL
Inventory growing faster than revenue
Inventory +13.8% ($564.0M to $642.0M) vs revenue -3.0% ($3.8B to $3.7B), +16.8 pts apart
10-K · XBRL
Critical audit matters changed
New this year: Goodwill - Implant and Prosthetic Solutions Reporting Unit (“The Company’s evaluation of goodwill for impairment involves the comparison of the fair value of each reporting unit to its carrying value. The Company used the discounted cash flow model to estimate the fair value of its reporting units, which requires management to make significant estimates and a”)
10-K · XBRL
Accounting checks
8 other checks clear, 3 worth a look
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
2 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

3facts worth reading about the other 8 checks found nothing to note

  • Receivables growing faster than revenue
    Receivables +23.7% ($556.0M to $688.0M) vs revenue -3.0% ($3.8B to $3.7B), +26.7 pts apart
  • Inventory growing faster than revenue
    Inventory +13.8% ($564.0M to $642.0M) vs revenue -3.0% ($3.8B to $3.7B), +16.8 pts apart
  • Critical audit matters changed
    New this year: Goodwill - Implant and Prosthetic Solutions Reporting Unit (“The Company’s evaluation of goodwill for impairment involves the comparison of the fair value of each reporting unit to its carrying value. The Company used the discounted cash flow model to estimate the fair value of its reporting units, which requires management to make significant estimates and a”)
  • Cash from operations $235.0M vs net income −$598.0M (FY ending Dec 31, 2025)
7 more checks with nothing to note
  • Same auditor in both 10-Ks: Deloitte & Touche LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

21 paragraphs in Risk Factors that were not in the 10-K filed Feb 27, 2025. Quoted as filed.

All 21 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
    Like other large, global companies, during the normal course of business, we have experienced and expect to continue to experience cyber threats, attacks and other attempts to compromise our information systems, with such attacks and threats rapidly increasing in both sophistication and frequency. Although past cybersecurity incidents…
  2. Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
    Additionally, federal and state privacy and security-related laws may be more restrictive than HIPAA and could impose additional penalties: •For example, the Federal Trade Commission uses its consumer protection authority to initiate enforcement actions in response to alleged privacy violations and data breaches.
  3. Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
    We generate a substantial portion of our revenue through a limited number of distributors who we also rely on to provide important service and support to end-users. We have attempted to mitigate any risks related to this concentration through diversifying our distributor base, particularly in the United States beginning in 2026.
  4. Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
    For further information regarding the specifics of our impairments, see Note 11, Goodwill and Intangible Assets, in the Notes to Consolidated Financial Statements in Item 8 of this Form 10-K. Our intellectual property may not protect our products, and/or our products may infringe on the intellectual property rights of third parties.

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$3.9B$4.0B$3.8B$3.7B
Net income−$950.0M−$132.0M−$910.0M−$598.0M
Operating cash flow$517.0M$377.0M$461.0M$235.0M
Free cash flow$368.0M$228.0M$281.0M$104.0M

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$3.7B ▼ 3.0% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

2 filings in the last 30 days · SEC EDGAR

All filings

About the company

DENTSPLY SIRONA Inc., Charlotte, NC · from the 10-K filed Feb 26, 2026

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) is the world’s largest diversified manufacturer of professional dental products and technologies, with a 139-year history of innovation and service to the dental industry and a vision of improving oral health and continence care globally. Dentsply Sirona develops, manufactures, and markets comprehensive solutions, including technologically advanced dental equipment supported by cloud-enabled software solutions as well as dental products and healthcare consumable products in urology and enterology under a strong portfolio of world-class brands.

Headquarters
Charlotte, NC
Country
United States
Reports in
USD
Listed on
Nasdaq
Fiscal year ends
December 31
Last results
Nov 5, 2026
Incorporated in
DE

Email alerts

Sources

The 10-K filed Feb 26, 2026 (open at SEC), compared with the 10-K filed Feb 27, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/XRAY/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.